Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,567 | 2,842 | 6,722 | 0 | 4,100 |
| Cost of Goods | 1,607 | 2,281 | 4,136 | 0 | N/A |
| Gross Profit | 959 | 560 | 2,586 | N/A | 4,100 |
| Operating Expenses | 31,047 | 26,559 | 17,801 | 13,368 | 9,924 |
| Operating Income | -29,480 | -25,717 | -15,079 | -13,368 | -5,825 |
| Interest Expense | 631 | 283 | 127 | 0 | 0 |
| Other Income | 87 | 1,006 | 305 | 505 | 22 |
| Pre-tax Income | -30,024 | -24,994 | -14,901 | -12,863 | -5,802 |
| Net Income Continuous | -30,024 | -24,994 | -14,901 | -12,863 | -5,802 |
| Net Income | $-30,024 | $-24,994 | $-14,901 | $-12,863 | $-5,802 |
| EPS Basic Total Ops | -30.80 | -28.00 | -16.80 | -27.60 | -59.60 |
| EPS Basic Continuous Ops | -30.96 | -27.83 | -16.64 | -27.41 | -48.97 |
| EPS Diluted Total Ops | -30.80 | -28.00 | -16.80 | -27.60 | -59.60 |
| EPS Diluted Continuous Ops | -30.96 | -27.83 | -16.64 | -27.41 | -48.97 |
| EPS Diluted Before Non-Recurring Items | -30.80 | -28.00 | -16.80 | -27.60 | N/A |
| EBITDA(a) | $-28,295 | $-24,582 | $-14,361 | $-12,824 | $-5,252 |